242 related articles for article (PubMed ID: 28561278)
21. Fasting hyperinsulinemia in human immunodeficiency virus-infected men: relationship to body composition, gonadal function, and protease inhibitor use.
Hadigan C; Corcoran C; Stanley T; Piecuch S; Klibanski A; Grinspoon S
J Clin Endocrinol Metab; 2000 Jan; 85(1):35-41. PubMed ID: 10634360
[TBL] [Abstract][Full Text] [Related]
22. Testosterone supplementation of megestrol therapy does not enhance lean tissue accrual in men with human immunodeficiency virus-associated weight loss: a randomized, double-blind, placebo-controlled, multicenter trial.
Mulligan K; Zackin R; Von Roenn JH; Chesney MA; Egorin MJ; Sattler FR; Benson CA; Liu T; Umbleja T; Shriver S; Auchus RJ; Schambelan M;
J Clin Endocrinol Metab; 2007 Feb; 92(2):563-70. PubMed ID: 17090640
[TBL] [Abstract][Full Text] [Related]
23. Effects of estradiol on fat in men undergoing androgen deprivation therapy: a randomized trial.
Russell N; Hoermann R; Cheung AS; Zajac JD; Handelsman DJ; Grossmann M
Eur J Endocrinol; 2021 Nov; 186(1):9-23. PubMed ID: 34678758
[TBL] [Abstract][Full Text] [Related]
24. Effects of testosterone supplementation on body composition and lower-body muscle function during severe exercise- and diet-induced energy deficit: A proof-of-concept, single centre, randomised, double-blind, controlled trial.
Pasiakos SM; Berryman CE; Karl JP; Lieberman HR; Orr JS; Margolis LM; Caldwell JA; Young AJ; Montano MA; Evans WJ; Vartanian O; Carmichael OT; Gadde KM; Johannsen NM; Beyl RA; Harris MN; Rood JC
EBioMedicine; 2019 Aug; 46():411-422. PubMed ID: 31358477
[TBL] [Abstract][Full Text] [Related]
25. Oral anabolic steroid treatment, but not parenteral androgen treatment, decreases abdominal fat in obese, older men.
Lovejoy JC; Bray GA; Greeson CS; Klemperer M; Morris J; Partington C; Tulley R
Int J Obes Relat Metab Disord; 1995 Sep; 19(9):614-24. PubMed ID: 8574271
[TBL] [Abstract][Full Text] [Related]
26. Loss of lean body and muscle mass correlates with androgen levels in hypogonadal men with acquired immunodeficiency syndrome and wasting.
Grinspoon S; Corcoran C; Lee K; Burrows B; Hubbard J; Katznelson L; Walsh M; Guccione A; Cannan J; Heller H; Basgoz N; Klibanski A
J Clin Endocrinol Metab; 1996 Nov; 81(11):4051-8. PubMed ID: 8923860
[TBL] [Abstract][Full Text] [Related]
27. A randomized, double-blind, placebo-controlled trial of testosterone gel on body composition and health-related quality-of-life in men with hypogonadal to low-normal levels of serum testosterone and symptoms of androgen deficiency over 6 months with 12 months open-label follow-up.
Behre HM; Tammela TL; Arver S; Tolrá JR; Bonifacio V; Lamche M; Kelly J; Hiemeyer F; ; Giltay EJ; Gooren LJ
Aging Male; 2012 Dec; 15(4):198-207. PubMed ID: 22834649
[TBL] [Abstract][Full Text] [Related]
28. Low-dose growth hormone treatment with diet restriction accelerates body fat loss, exerts anabolic effect and improves growth hormone secretory dysfunction in obese adults.
Kim KR; Nam SY; Song YD; Lim SK; Lee HC; Huh KB
Horm Res; 1999; 51(2):78-84. PubMed ID: 10352397
[TBL] [Abstract][Full Text] [Related]
29. The effects of growth hormone on body composition and physical performance in recreational athletes: a randomized trial.
Meinhardt U; Nelson AE; Hansen JL; Birzniece V; Clifford D; Leung KC; Graham K; Ho KK
Ann Intern Med; 2010 May; 152(9):568-77. PubMed ID: 20439575
[TBL] [Abstract][Full Text] [Related]
30. Effects of testosterone on muscle strength, physical function, body composition, and quality of life in intermediate-frail and frail elderly men: a randomized, double-blind, placebo-controlled study.
Srinivas-Shankar U; Roberts SA; Connolly MJ; O'Connell MD; Adams JE; Oldham JA; Wu FC
J Clin Endocrinol Metab; 2010 Feb; 95(2):639-50. PubMed ID: 20061435
[TBL] [Abstract][Full Text] [Related]
31. Effect of testosterone supplementation on functional mobility, cognition, and other parameters in older men: a randomized controlled trial.
Emmelot-Vonk MH; Verhaar HJ; Nakhai Pour HR; Aleman A; Lock TM; Bosch JL; Grobbee DE; van der Schouw YT
JAMA; 2008 Jan; 299(1):39-52. PubMed ID: 18167405
[TBL] [Abstract][Full Text] [Related]
32. Body composition and hormonal adaptations associated with forskolin consumption in overweight and obese men.
Godard MP; Johnson BA; Richmond SR
Obes Res; 2005 Aug; 13(8):1335-43. PubMed ID: 16129715
[TBL] [Abstract][Full Text] [Related]
33. Testosterone replacement therapy of opioid-induced male hypogonadism improved body composition but not pain perception: a double-blind, randomized, and placebo-controlled trial.
Glintborg D; Vaegter HB; Christensen LL; Bendix E; Graven-Nielsen T; Andersen PG; Andersen M
Eur J Endocrinol; 2020 Jun; 182(6):539-548. PubMed ID: 32213659
[TBL] [Abstract][Full Text] [Related]
34. Effect of testosterone treatment on body composition and muscle strength in men over 65 years of age.
Snyder PJ; Peachey H; Hannoush P; Berlin JA; Loh L; Lenrow DA; Holmes JH; Dlewati A; Santanna J; Rosen CJ; Strom BL
J Clin Endocrinol Metab; 1999 Aug; 84(8):2647-53. PubMed ID: 10443654
[TBL] [Abstract][Full Text] [Related]
35. Effect of orlistat on weight and body composition in obese adolescents: a randomized controlled trial.
Chanoine JP; Hampl S; Jensen C; Boldrin M; Hauptman J
JAMA; 2005 Jun; 293(23):2873-83. PubMed ID: 15956632
[TBL] [Abstract][Full Text] [Related]
36. Time on androgen deprivation therapy and adaptations to exercise: secondary analysis from a 12-month randomized controlled trial in men with prostate cancer.
Taaffe DR; Buffart LM; Newton RU; Spry N; Denham J; Joseph D; Lamb D; Chambers SK; Galvão DA
BJU Int; 2018 Feb; 121(2):194-202. PubMed ID: 28872752
[TBL] [Abstract][Full Text] [Related]
37. Testosterone replacement in young male cancer survivors: A 6-month double-blind randomised placebo-controlled trial.
Walsh JS; Marshall H; Smith IL; Greenfield DM; Swain J; Best E; Ashton J; Brown JM; Huddart R; Coleman RE; Snowden JA; Ross RJ
PLoS Med; 2019 Nov; 16(11):e1002960. PubMed ID: 31714912
[TBL] [Abstract][Full Text] [Related]
38. Effect of testosterone treatment on glucose metabolism in men with type 2 diabetes: a randomized controlled trial.
Gianatti EJ; Dupuis P; Hoermann R; Strauss BJ; Wentworth JM; Zajac JD; Grossmann M
Diabetes Care; 2014 Aug; 37(8):2098-107. PubMed ID: 24804695
[TBL] [Abstract][Full Text] [Related]
39. Whole-body oxidative stress reduction during testosterone therapy in aging men: A randomized placebo-controlled trial.
Christensen LL; Poulsen HE; Andersen MS; Glintborg D
Andrology; 2024 Jan; 12(1):115-122. PubMed ID: 37177884
[TBL] [Abstract][Full Text] [Related]
40. Offspring body size and metabolic profile - effects of lifestyle intervention in obese pregnant women.
Tanvig M
Dan Med J; 2014 Jul; 61(7):B4893. PubMed ID: 25123127
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
